Device recalls aren’t slowing down — and the FDA has acknowledged it doesn’t have the capacity to manage the current volume. For supply chain leaders already absorbing cost pressure, tariff uncertainty and a tight labor market, the practical question isn’t whether a recall will hit their system. It’s whether they’ll be ready when it does.
Here are five things to know:
- High-severity actions since January include Boston Scientific pacemakers recalled after four deaths and 2,500 injuries, Abbott glucose sensors recalled amid seven deaths and hundreds of injuries, a J&J MedTech neuro device recalled after four injuries and one death, and Medtronic’s heart vent catheter and two Abiomed heart pumps tied to injuries.
- For Medline, recall actions included a blood culture kit recall in February, a syringe defect recall that expanded into FDA alerts on surgical kits in April, and a separate expanded catheter recall in March.
- This spring, the FDA expanded its AI capabilities and piloted one-day inspections to speed detection — but, a December 2025 Government Accountability Office report found the agency still couldn’t meet its own three-month goal for terminating recalls due to resource constraints. Of the nearly 4,000 recalls initiated from 2020 to 2024, 62% were still ongoing at the time of the report. Some stakeholders told GAO the delays directly affect patient care.
- Vendor concentration is adding risk. Systems that consolidate purchasing under a single primary vendor for cost savings have limited backup sourcing options when that vendor is involved in multiple recall actions in the same quarter. Banner Health has rethought how its group purchasing organization structure generates savings, and CommonSpirit has moved to grow its own GPO — both reflecting the tradeoff large systems are weighing between consolidation and resilience.
- The cost backdrop hasn’t eased. Medical supply chain costs were projected to increase 2.41% in 2026, per Vizient, and hospital costs are rising fastest in device-intensive categories. Supply chain leaders told Becker’s disruption and cost are what keeps them up at night. A high-severity recall is both at once.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.